feed,title,long_url,short_url
SeekingAlpha,Cassava Sciences responds to simufilam study allegations in The New York Times,https://seekingalpha.com/news/3827218,
SeekingAlpha,"Ambrx Biopharma GAAP EPS of -$0.48 misses by $0.03, revenue of $7.46M misses by $4.51M",https://seekingalpha.com/news/3827223,
SeekingAlpha,Canopy Growth announces initiatives to cut costs,https://seekingalpha.com/news/3827222,
SeekingAlpha,Lucid Group gains on ten-year EV deal with Saudi Arabian government,https://seekingalpha.com/news/3827221,
SeekingAlpha,"Microsoft dips as Q3 revenues top expectations, led by cloud strength",https://seekingalpha.com/news/3826689,
SeekingAlpha,"Industrial Logistics Properties GAAP EPS of -$0.10, rental income of $71.38M",https://seekingalpha.com/news/3827220,
SeekingAlpha,"Renasant Non-GAAP EPS of $0.60 beats by $0.03, revenue of $137.09M misses by $6.39M",https://seekingalpha.com/news/3827219,
